UHT

Universal Health Realty Income Trust [UHT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

UHT Stock Summary

Top 10 Correlated ETFs

UHT


Top 10 Correlated Stocks

UHT


In the News

11:58 28 Mar 2024 UHT

7 Upcoming Dividend Increases

Companies that consistently increase their dividends perform better than those that don't. The article provides insights on upcoming dividend increases for investors to consider. With two weeks left, it's last call for dividend increases for 2023.

08:05 28 Mar 2024 UHT

Universal Health Realty: Decent Income At A Great Price

Universal Health Realty's asset base is mostly comprised of safer Medical Office Buildings. UHT pays a well-covered dividend and carries a strong balance sheet. Recent share price weakness presents a nice opportunity for income investors.

08:05 28 Mar 2024 UHT

Sell Alert: 2 REITs Getting Risky

Most REITs are heavily discounted. But not all REITs are worth buying.

03:15 28 Mar 2024 UHT

Universal Health Realty: An Undervalued 6% Yield

UHT has high exposure to Medical Office buildings and has a long track record of raising its dividend. It should benefit from long-term demographic tailwinds with growing healthcare spend.

05:56 28 Mar 2024 UHT

3 Dividend Juggernauts Trading at Bargain Prices

When investors think of dividend stocks, oftentimes our minds go straight to the gold standard of dividend payers: the Dividend Aristocrats, which are S&P 500 stocks that have not only paid but grown their dividends for 25 years or more.

03:07 28 Mar 2024 UHT

Universal Health Realty Remains Cheap Even After A Rebound

UHT has outperformed the broader real estate index this year, especially after its recent rebound. Third quarter earnings weren't as bad as the market expected.

05:48 28 Mar 2024 UHT

Universal Health Realty Income Trust: A Decent Play At A Fair Price

Universal Health Realty Income Trust has done well to grow its top and bottom lines in a steady fashion over the past few years. Long term, the company's future is likely positive, but this doesn't make the company a great investment.

07:15 28 Mar 2024 UHT

Want to Get Richer? Invest in These Stocks and Wait 10 Years.

REITs can help you win the wealth game with little effort.

12:17 28 Mar 2024 UHT

6 Dividend Stocks to Buy in July With Yields Over 5%

These dividend stocks have attractive yields over 5.0% and growing earnings that cover the payments, making them stocks worth buying. The post 6 Dividend Stocks to Buy in July With Yields Over 5% appeared first on InvestorPlace.

08:30 28 Mar 2024 UHT

Universal Health Realty: The Market Overreacted To Floating Rate Debt

A significant amount of UHT's debt is in the form of floating rate line of credit borrowings, which makes the REIT vulnerable to rising interest rates. That said, UHT survived the last rate-hiking cycle with a similar proportion of floating rate debt, suffering only a temporary and small dip in earnings.

UHT Financial details

Company Rating
Strong Buy
Market Cap
492.41M
Income
15.18M
Revenue
95.58M
Book val./share
14.57
Cash/share
0.6
Dividend
2.88
Dividend %
6.93%
Employees
-
Optionable
No
Shortable
Yes
Earnings
23 Apr 2024
P/E
67.53
Forward P/E
-
PEG
-2.61
P/S
6.02
P/B
2.73
P/C
61.1
P/FCF
11.03
Quick Ratio
0.32
Current Ratio
0.32
Debt / Equity
1.79
LT Debt / Equity
1.73
-
-
EPS (TTM)
1.1
EPS next Y
-
EPS next Q
1.58
EPS this Y
-262.32%
EPS next Y
-
EPS next 5Y
792.91%
EPS last 5Y
18.47%
Revenue last 5Y
4.37%
Revenue Q/Q
0.4%
EPS Q/Q
-7.14%
-
-
-
-
SMA20
-12.29%
SMA50
-14.57%
SMA100
-7.2%
Inst Own
53.47%
Inst Trans
0.83%
ROA
1%
ROE
4%
ROC
0.12%
Gross Margin
94%
Oper. Margin
35%
Profit Margin
9%
Payout
350%
Shs Outstand
13.82M
Shs Float
13.52M
-
-
-
-
Target Price
-
52W Range
34.85-49.64
52W High
-25.18%
52W Low
+7.82%
RSI
43.79
Rel Volume
0.94
Avg Volume
94.11K
Volume
88.89K
Perf Week
3.38%
Perf Month
-4.75%
Perf Quarter
-9.41%
Perf Half Y
-10.98%
-
-
-
-
Beta
0.804
-
-
Volatility
0.48%, 2.08%
Prev Close
3.79%
Price
36.66
Change
1.86%

UHT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.625.686.126.586.93
Net income per share
0.480.697.94-0.691.12
Operating cash flow per share
3.113.223.473.43.15
Free cash flow per share
2.733.052.522.412.6
Cash per share
0.440.421.641.420.6
Book value per share
13.2311.5717.1116.6414.58
Tangible book value per share
12.1710.7216.3815.9513.91
Share holders equity per share
13.2311.5717.1116.6414.58
Interest debt per share
21.3522.7225.3726.5127.74
Market cap
1.61B883.26M818.13M657.29M596.24M
Enterprise value
1.89B1.18B1.14B1B958.44M
P/E ratio
242.8993.197.49-68.7338.72
Price to sales ratio
20.8911.329.727.256.24
POCF ratio
37.7819.9817.1414.0413.71
PFCF ratio
42.9221.0623.5519.8116.63
P/B Ratio
8.875.553.482.872.97
PTB ratio
8.875.553.482.872.97
EV to sales
24.4715.1513.4911.0810.03
Enterprise value over EBITDA
35.3522.1719.5417.1914.52
EV to operating cash flow
44.2726.7323.821.4522.05
EV to free cash flow
50.2928.1732.730.2526.73
Earnings yield
00.010.13-0.010.03
Free cash flow yield
0.020.050.040.050.06
Debt to equity
1.561.911.451.551.79
Debt to assets
0.580.620.570.580.6
Net debt to EBITDA
5.185.65.475.935.49
Current ratio
0.070.060.410.340.31
Interest coverage
2.623.353.482.961.67
Income quality
2.252.270.442.222.82
Dividend Yield
0.020.040.050.060.07
Payout ratio
5.644.010.35-4.12.58
Sales general and administrative to revenue
0.050.05000
Research and developement to revenue
00000
Intangibles to total assets
0.030.020.020.020.02
Capex to operating cash flow
-0.12-0.05-0.27-0.29-0.18
Capex to revenue
-0.07-0.03-0.15-0.15-0.08
Capex to depreciation
-0.2-0.09-0.48-0.52-0.27
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
11.9913.455.2616.1219.14
ROIC
0.020.030.05-0.020.13
Return on tangible assets
0.010.020.19-0.020.03
Graham Net
-21.34-23.37-19.62-21.19-22.78
Working capital
-209.5M-239.91M-167.71M-206.3M-234.75M
Tangible asset value
167.18M147.26M225.36M219.65M191.82M
Net current asset value
-290.34M-318.56M-246.4M-273.39M-289.6M
Invested capital
1.561.911.451.551.79
Average receivables
10.41M10.65M52.45M95.81M97.53M
Average payables
00000
Average inventory
000-6M-6M
Days sales outstanding
50.1550.08408.35392.43372.83
Days payables outstanding
00000
Days of inventory on hand
000-859.330
Receivables turnover
7.287.290.890.930.98
Payables turnover
00000
Inventory turnover
2133525B00-0.420
ROE
0.040.060.46-0.040.08
Capex per share
-0.37-0.16-0.94-0.99-0.55

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.751.691.731.761.76
Net income per share
-0.220.060.50.280.26
Operating cash flow per share
0.890.730.890.740.77
Free cash flow per share
1.881.120.890.190.77
Cash per share
1.421.341.480.610.6
Book value per share
16.6316.1215.7215.2514.57
Tangible book value per share
15.9415.4815.1114.5513.91
Share holders equity per share
16.6316.1215.7215.2514.57
Interest debt per share
25.9626.4226.627.2826.51
Market cap
657.58M662.86M655.84M557.53M596.46M
Enterprise value
1B1.02B1.01B920.94M958.66M
P/E ratio
-53.05217.4723.583641.5
Price to sales ratio
27.2528.5427.5523.0224.53
POCF ratio
53.5165.8453.5254.8655.84
PFCF ratio
25.3842.9353.52217.4555.96
P/B Ratio
2.872.983.032.652.97
PTB ratio
2.872.983.032.652.97
EV to sales
41.6243.7142.3838.0239.42
Enterprise value over EBITDA
64.8468.7169.5759.9956.33
EV to operating cash flow
81.72100.8282.3390.6389.75
EV to free cash flow
38.7665.7482.33359.1889.94
Earnings yield
000.010.010.01
Free cash flow yield
0.040.020.0200.02
Debt to equity
1.551.621.671.771.79
Debt to assets
0.580.60.60.610.6
Net debt to EBITDA
22.3823.8424.3523.6721.28
Current ratio
0.340.330.330.320.31
Interest coverage
2.682.211.831.871.58
Income quality
2.182.263.532.622.97
Dividend Yield
0.010.010.020.020.02
Payout ratio
-3.1812.931.442.562.78
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.020.010.010.020.02
Capex to operating cash flow
1.110.530-0.750
Capex to revenue
0.560.230-0.310
Capex to depreciation
2.10.820-1.090
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
9.174.4813.359.829.24
ROIC
-0.0100.0300.03
Return on tangible assets
-0.0100.010.010.01
Graham Net
-21.18-21.44-21.65-22.9-22.77
Working capital
-206.3M-213.09M-217.04M-229.34M-234.75M
Tangible asset value
219.65M213.29M208.29M200.66M191.82M
Net current asset value
-273.39M-276.13M-279.45M-291.28M-289.6M
Invested capital
1.551.621.671.771.79
Average receivables
97.2M97.66M97.83M97.85M97.78M
Average payables
00000
Average inventory
-12.25M-11.15M-10.65M-5.5M0
Days sales outstanding
363.45379.32369.61363.88361.28
Days payables outstanding
00000
Days of inventory on hand
-824.43-711.98-748.300
Receivables turnover
0.250.240.240.250.25
Payables turnover
00000
Inventory turnover
-0.11-0.13-0.1200
ROE
-0.0100.030.020.02
Capex per share
0.990.390-0.550

UHT Frequently Asked Questions

What is Universal Health Realty Income Trust stock symbol ?

Universal Health Realty Income Trust is a US stock , located in King of prussia of Pa and trading under the symbol UHT

What is Universal Health Realty Income Trust stock quote today ?

Universal Health Realty Income Trust stock price is $36.66 today.

Is Universal Health Realty Income Trust stock public?

Yes, Universal Health Realty Income Trust is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap